StockDuty ← Dashboard Oct 29, 2026 06:07 PM ET
SignalCorporate

Preclinical CRO - Global Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Adoption and Outsourcing Propel Revenue to USD 11.74 Billion

AI adoption and outsourcing drive preclinical CRO revenue to USD 11.74 billion by 2031.

What happened: ResearchAndMarkets.com added a preclinical CRO market report covering 2026 to 2031, projecting growth from USD 8.20 billion to USD 11.74 billion. Key numbers: USD 8.20 billion in 2026; USD 11.74 billion by 2031; 7.45% CAGR; toxicology 40.55% of 2025 market; safety pharmacology 12.25% CAGR; North America 45.13% of 2025 revenue; Why it matters: The report attributes growth to rising pharmaceutical R&D spending, expanding drug pipelines, and outsourcing, while citing data standardization problems such as SEND validation errors affecting 38% of IND submissions in 2024. Market: +0.7% today ($29.64), +21.7% YTD, 0.4x vol — as of 18:03 UTC Coverage: 3 outlets in 24h
ResearchAndMarkets.com added a preclinical CRO market report covering 2026 to 2031, projecting growth from USD 8.20 billion to USD 11.74 billion.
The report attributes growth to rising pharmaceutical R&D spending, expanding drug pipelines, and outsourcing, while citing data standardization problems such as SEND validation errors affecting 38% of IND submissions in 2024. Market: +0.7% today ($29.64), +21.7% YTD, 0.4x vol — as of 18:03 UTC
Sources